Innate Pharma reports third quarter 2020 financial results and business updateGlobeNewsWire • 11/17/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHAPRNewsWire • 11/14/20
Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary SyndromeGlobeNewsWire • 11/13/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm - IPHANewsfile Corp • 11/09/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm - IPHANewsfile Corp • 11/07/20
IPHA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Innate Pharma S.A. Investors of Class Action and Lead Plaintiff Deadline: December 22, 2020Newsfile Corp • 11/06/20
IPHA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Innate Pharma S.A. Shareholders of Class Action and Lead Plaintiff Deadline: December 22, 2020Business Wire • 11/02/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important Deadline in First Filed Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - IPHAPRNewsWire • 10/31/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Innate Pharma SA (IPHA) InvestorsBusiness Wire • 10/30/20
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Innate Pharma SA (IPHA) InvestorsBusiness Wire • 10/30/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Innate Pharma SA (IPHA) InvestorsBusiness Wire • 10/30/20
The Law Offices of Frank R. Cruz Announces Investigation of Innate Pharma SA (IPHA) on Behalf of InvestorsBusiness Wire • 10/29/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Innate Pharma SA (IPHA) on Behalf of InvestorsBusiness Wire • 10/29/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Innate Pharma SA (IPHA) on Behalf of InvestorsBusiness Wire • 10/29/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Innate Pharma S.A. Investors of Important Deadline in Securities Class Action – IPHABusiness Wire • 10/28/20
Shareholder Alert: Robbins LLP Announces It Is Investigating Innate Pharma S.A. (IPHA) for Misleading ShareholdersPRNewsWire • 10/27/20
Rosen, A Global and Leading Law Firm, First Files Securities Class Action Lawsuit Against Innate Pharma S.A.; Encourages Investors with Losses in Excess of $100K to Contact Firm - IPHANewsfile Corp • 10/26/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/26/20
IPHA LOSS NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Innate Pharma S.A. - IPHAPRNewsWire • 10/25/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/24/20
IPHA LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Innate Pharma S.A. – IPHABusiness Wire • 10/24/20
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Innate Pharma S.A. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 10/23/20
First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZenecaGlobeNewsWire • 10/23/20
SHAREHOLDER ALERT: Investigation of Innate Pharma Announced by Holzer & Holzer, LLCNewsfile Corp • 10/22/20
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Innate Pharma S.A. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 10/21/20
